Eam Investors, LLC Pacira Bio Sciences, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$51.49 - $81.64 $2.32 Million - $3.69 Million	-45,145 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $2.71 Million - $3.45 Million	45,145 New	45,145 $3.45 Million
Q4 2020 Feb 11, 2021	SELL	$50.47 - $66.26 $1.35 Million - $1.78 Million	-26,798 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $537,317 - $651,357	-10,339 Reduced 27.84%	26,798 $1.61 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $1.14 Million - $1.95 Million	37,137 New	37,137 $1.95 Million

254

48.5M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.21B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.